• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

Silent Gilead management

Anonymous

Guest
Where is Gilead managements response to allowing a clearly inferior product curbstomp you and your shareholders? This express scripts deal is killing Gilead stock. Killing the entire biotech sector.